许海恒
发布时间:2025年10月16日
浏览次数:

电子邮箱:hhxu@xzhmu.edu.cn

许海恒,博士,讲师。2024年,获南京大学博士学位。入选江苏省“双创博士”。研究方向为基于工程化微生物的肿瘤免疫治疗、在体制备CAR-T细胞治疗实体瘤的效果和机制研究,以第一/通讯作者(含共同)在Advanced Materials、Nature Biomedical Engineering、Nano Research等期刊发表SCI论文5篇。授权中国发明专利2项。主持江苏省高校自然科学基金面上项目,江苏省高校科协青年科技人才培育计划等项目,参与国家重点研发计划。现为中国民族医药协会肿瘤学分会委员、江苏省高等学校科学技术协会会员。

代表论文:

1.Haiheng Xu, Shuqin Xiong, Yiyun Chen, Qingsong Ye, Nan Guan, Yiqiao Hu, Jinhui Wu*. Flagella of tumor - targeting bacteria trigger local hemorrhage to reprogram tumor‐associated macrophages for improved antitumor therapy[J].Advanced Materials, 2023, 35(38):2303357.(IF=27.4)

2.Wenguang Wang#,Haiheng Xu#, Qingsong Ye#, Feng Tao, Ian Wheeldon, Ahu Yuan, Yiqiao Hu*, Jinhui Wu*. Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria[J].Nature Biomedical Engineering, 2022, 6(1): 44-53.(IF=28.1, co-first author)

3.Haiheng Xu#, Shuqin Xiong#, Deyuan Zheng#, Lan An, Yiyun Chen, Lei Wang*, Xuehui Rui*, Jinhui Wu*.Tumor intracellular self-assembled nanoparticles induced by bacteria elicited erythrocyte infiltration realize antitumor efficacy of zoledronate[J].Nano Research,2025, 18(9): 94907827. (IF=9.0)

4.Deyuan Zheng#, Junhong Yao#,Haiheng Xu#*, Shuqin Xiong, Qingsong Ye, Yiyun Chen, Chuan Zhao, Min Zhang, Xuehui Rui*, Jinhui Wu*.Bacteria outer membrane-based oxygen gels alleviate tumor hypoxia for enhanced systemic immune response of radiotherapy[J].Science China-Materials, 2025. (IF=7.4, co-first author)

5.Zhuo Feng#, Yuchen Wang#,Haiheng Xu, Yunfei Guo, Wen Xia, Chenxuan Zhao, Xiaozhi Zhao*, Jinhui Wu*. Recent advances in bacterial therapeutics based on sense and response[J].Acta Pharmaceutica Sinica B, 2023, 13(3): 1014-1027.(IF=14.7)

6.Haiheng Xu, Yiqiao Hu*, Jinhui Wu*. Flagellated bacterial porter for in situ tumor vaccine[J].Microbial Cell, 2022, 9(9): 158-161.(IF=4.6)

人才队伍